Trial NCT04616560

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2020-08428
Secondary IDs: NCI-2020-08428 PEPN1924 UM1CA228823

Last trial update was posted on 2024-04-03

MeSH Interventions

Camptothecin Immunoconjugates Trastuzumab Trastuzumab deruxtecan

MeSH Conditions

Osteosarcoma Recurrence

Other Conditions

Recurrent Osteosarcoma

Stopping Reasons

Other - Stage 1 has met accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID